Continuing our Biopharma Innovators Series in partnership with NewYorkBIO, we welcome a recognized leader at the forefront of innovation in clinical research and medicine development.
Craig Lipset, former Head of Clinical Innovation at Pfizer, discusses where real world data (RWD) fits within the context of the clinical trial continuum, and innovative ways RWD can be used to drive better planned and executed studies as well as to drive greater efficiency.
Stay tuned for more of our weekly Biopharma Innovators Series, where you’ll hear New York-based industry experts on a wide range of important issues, from helping patients navigate clinical trials, to real world evidence and value for innovation, to bringing lower priced drugs to market, and more. And to catch some of these experts live and in person, be sure to register for the rescheduled 2020 Annual Meeting on September 14th!
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].